Insider · CIK 0001899935

Sensenig Bethany

Reports to the SEC for 4 companies · FRAMINGHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001899935

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2026-04-16	ACOGAlpha Cognition Inc.A Award	Director	AAward	+5,489 sh	—	—	5,489
2026-04-16	ACOGAlpha Cognition Inc. · Common Share OptionsA Award	Director	AAward	+6,991 sh	—	—	6,991
2026-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,475 sh	—	—	4,475
2026-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,217 sh	$50.31	−$61.2K	3,258
2026-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,258 sh	$51.27	−$167K	0
2026-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,475 sh	—	—	0
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+2,989 sh	—	—	2,989
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+4,977 sh	—	—	4,977
2025-10-01	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-08-14	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,369 sh	$42.25	−$227K	0
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+5,369 sh	—	—	5,369
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,369 sh	—	—	0
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,296 sh	—	—	7,296
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+4,475 sh	—	—	4,475
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+8,252 sh	—	—	8,252
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,369 sh	—	—	5,369
2023-08-17	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+24.2K sh	—	—	24,153
2023-04-21	9 METERS BIOPHARMA, INC.S Sale	Chief Financial Officer	SSale	−9,100 sh	$1.21	−$11K	41,077
2023-03-27	9 METERS BIOPHARMA, INC.A Award	Chief Financial Officer	AAward	+50.2K sh	—	—	50,177
2022-01-18	9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+1.3M sh	—	—	1,300,000

Recent filings

Accepted (ET)
Jun 114
Sensenig Bethany0001899935-26-000007
SEC(opens sec.gov)
Apr 174
Sensenig Bethany0000912282-26-000624
SEC(opens sec.gov)
Feb 234
Sensenig Bethany0001899935-26-000005
SEC(opens sec.gov)
Feb 204
Sensenig Bethany0001899935-26-000003
SEC(opens sec.gov)
Oct 24
Sensenig Bethany0001899935-25-000005
SEC(opens sec.gov)
Aug 184
Sensenig Bethany0001628280-25-040668
SEC(opens sec.gov)
Feb 244
Sensenig Bethany0001628280-25-007459
SEC(opens sec.gov)
Feb 214
Sensenig Bethany0001628280-25-007182
SEC(opens sec.gov)
Feb 264
Sensenig Bethany0001104659-24-027575
SEC(opens sec.gov)
Aug 214
Sensenig Bethany0001104659-23-093982
SEC(opens sec.gov)
Apr 214
Sensenig Bethany0001551986-23-000026
SEC(opens sec.gov)
Mar 294
Sensenig Bethany0001578563-23-000009
SEC(opens sec.gov)

Companies

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702